Captor Therapeutics ® Investor Relations

      Investor Relations

      Information on transaction in Company shares under Article 19 MAR

      Publication date: 2022-05-05
      Number: RB ESPI 15/2022

      Current Report No. 15/2022

      Date of preparation: 5 May 2022

      Subject: Information on transaction in Company shares under Article 19 MAR

      Legal basis: Article 19(3) MAR – information on transactions carried out by persons discharging managerial responsibilities

      The Management Board of Captor Therapeutics S.A. based in Wrocław ("the Company") informs that it received from Florent Gros, Member of the Supervisory Board, the notification regarding transactions on the Company's shares (conclusion of a share subscription agreement) under Article 19(1) of the MAR Regulation. The share subscription agreement was entered into as part of the incentive program.

      The content of the notification is attached to this report.


      Attachments: